Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 14;217(5):759-766.
doi: 10.1093/infdis/jix612.

Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials

Sofie Biering-Sørensen  1   2 , Kristoffer Jarlov Jensen  1   2   3 , Ivan Monterio  1 , Henrik Ravn  2 , Peter Aaby  1   2 , Christine Stabell Benn  1   2   4
Affiliations

Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials

Sofie Biering-Sørensen et al. J Infect Dis. .

Abstract

Background: Three randomized trials (RCTs) in low-weight (<2.5 kg) infants have shown that Bacille Calmette-Guérin (BCG) vaccine nonspecifically reduces all-cause mortality in the neonatal period.

Methods: Using data from 3 RCTs of early BCG (n = 6583) we examined potential sex differences in the timing of the mortality reduction in the neonatal period, presenting metaestimates of the main outcome mortality rate ratios (MRR) for BCG-vaccinated and controls.

Results: Among controls, boys had a particularly high mortality during the first week after randomization: male-female MRR 2.71 (95% CI, 1.70-4.50). During the first week, BCG had a marked beneficial effect for boys, reducing mortality 3-fold (MRR [BCG/no BCG] = 0.36 [0.20-0.67]). In weeks 2-4 the effect waned for boys (MRR = 0.91 [0.51-1.69]). In girls, the pattern was opposite with a limited effect in the first week (MRR = 0.85 [0.46-1.54]), but a significant reduction in weeks 2-4 (MRR = 0.56 [0.31-1.00]). This was consistent in all 3 trials. Verbal autopsies linked early benefit to fewer sepsis-related deaths among BCG-vaccinated boys.

Discussion: The marked reduction in mortality in the days after BCG vaccination in boys emphasizes the importance of providing BCG soon after birth.

Trial registration numbers: ClinicalTrials.gov (NCT00146302) and ClinicalTrials.gov (NCT00625482).

Keywords: Bacille Calmette-Guérin vaccine; heterologous immunity; neonatal mortality; nonspecific effects of vaccines; sex differences.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Children enrolled in 3 trials of early BCG effects on neonatal mortality in Guinea-Bissau 2002–2013. Note: The flow of children in each trial has been described in detail elsewhere [3–5]. Abbreviation: BCG, Bacille Calmette-Guérin.
Figure 2.
Figure 2.
Mortality rates split into time intervals since randomization, presented by sex and randomization groups. Abbreviation: BCG, Bacille Calmette-Guérin.
Figure 3.
Figure 3.
Mortality curves for Trials 1, 2, and 3 combined and separately for Trial 2 and Trial 3. Note: It was not possible to calculate a separate mortality curve stratified by sex for Trial 1 due to few deaths within the neonatal period (n = 2 girls, n = 6 boys). Abbreviation: BCG, Bacille Calmette-Guérin.
See this image and copyright information in PMC

References

    1. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000; 321:1435–8. - PMC - PubMed
    1. Roth A, Jensen H, Garly ML et al. . Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J 2004; 23:544–50. - PubMed
    1. Aaby P, Roth A, Ravn H et al. . Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?J Infect Dis 2011; 204:245–52. - PubMed
    1. Biering-Sorensen S, Aaby P, Lund N et al. . Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial. Clin Infect Dis 2017; 657:1183–90. - PMC - PubMed
    1. Biering-Sørensen S, Aaby P, Napirna BM et al. . Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J 2012; 31:306–8. - PubMed

Publication types

Associated data